Taha I. Huda

High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer

Boris I. Chobrutskiy, Andrea Chobrutskiy, Saif Zaman et al. · Molecular Immunology · 2021 · 39 citations

Pharmacy, Bioinformatics, Oncology +17

Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity

Rachel A. Eakins, Andrea Chobrutskiy, Jamie K. Teer et al. · Molecular Immunology · 2022 · 28 citations

Life Sciences, Immunology, Oncology +17

Sequencing of Argonaute-bound microRNA/mRNA hybrids reveals regulation of the unfolded protein response by microRNA-320a

Christopher J. Fields, Li Lü, Nicholas M. Hiers et al. · PLoS Genetics · 2021 · 21 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas

Michelle Yeagley, Boris I. Chobrutskiy, Etienne C. Gozlan et al. · Pediatric Hematology and Oncology · 2021 · 18 citations

Life Sciences, Immunology, Oncology +17

Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates

Monica Hsiang, Boris I. Chobrutskiy, Michael J. Diaz et al. · Translational Oncology · 2021 · 18 citations · Full text

Life Sciences, Immunology, Oncology +17